Lynnette K Nieman

No ORCID on file · 29 papers in corpus · active 1995-2022

Study types

  • article 24
  • other 3
  • rct 1
  • review 1

Condition tags

  • endometriosis 25
  • chronic_pelvic_pain 7
  • adenomyosis 3
  • dysmenorrhea 2
  • infertility 1
review 2022
Current opinion in endocrinology, diabetes, and obesity ·doi:10.1097/med.0000000000000753

PURPOSE OF REVIEW: This review is intended to provide perspective on the history of selective progesterone receptor modulators (SPRMs) and progesterone antagonists, their current availability, therapeutic promise and safety concerns. RECEN…

article 2020
·doi:10.17615/v6py-2x81

To develop a model using individual and lesion characteristics to help surgeons choose lesions with a high probability of containing histologically-confirmed endometriosis.

article 2020
·doi:10.1016/j.biopsych.2020.02.421
article 2015

OBJECTIVE: To evaluate whether 6 months of raloxifene was effective in treatment of chronic pelvic pain in women with endometriosis. METHODS: Women with chronic pelvic pain and no endometriosis treatment for 6 months underwent lapa-roscopy …

article 2014
article 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.05.018
article 2011
Obstetrics and gynecology ·doi:10.1097/aog.0b013e318223fed0

OBJECTIVE: To study whether pain location is related to lesion location in women with chronic pelvic pain and biopsy-proven endometriosis. METHODS: A secondary analysis was performed to compare self-reported pain location with recorded lapa…

article 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.11.037
other 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.02.121

OBJECTIVE: To evaluate the expression of biomarkers of implantation, glycodelin A (GdA), osteopontin (OPN), lysophosphatidic acid receptor 3 (LPA3), and HOXA10, in eutopic endometrium of women with and without endometriosis. DESIGN: Prospe…

article 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.11.038
article 2008
Obstetrics and gynecology ·doi:10.1097/01.aog.0000297307.35024.b5

OBJECTIVE: To evaluate whether 6 months of raloxifene was effective in treatment of chronic pelvic pain in women with endometriosis. METHODS: Women with chronic pelvic pain and no endometriosis treatment for 6 months underwent laparoscopy f…

other 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.05.042

OBJECTIVE: To correlate histology with endometriosis characteristics. DESIGN: Secondary data analysis. SETTING: Government research hospital. PATIENT(S): One hundred thirty-three women with chronic pelvic pain and endometriosis who under…

article 2007
·doi:10.1016/j.fertnstert.2007.07.667
article 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.01.030
article 2005
·doi:10.1016/j.fertnstert.2005.07.300
article 2004
Fertility and Sterility ·doi:10.1016/j.fertnstert.2003.11.059
other 2004
Fertility and Sterility ·doi:10.1016/j.fertnstert.2003.10.040

OBJECTIVE: To determine whether urine VEGF is elevated in women with endometriosis. DESIGN: Prospective observational study. SETTING: Tertiary care government and private hospitals. PATIENT(S): During laparoscopy for pelvic pain or infer…

article 2003
·doi:10.1016/s0039-128x(03)00118-1
article 2003
·doi:10.1016/s0015-0282(03)01133-6
article 2003
Fertility and Sterility ·doi:10.1016/s0015-0282(03)00155-9
rct 2003
Human Reproduction ·doi:10.1093/humrep/deg342

BACKGROUND: Progesterone receptor modulators have potential therapeutic use in progesterone-dependent conditions such as endometriosis, fibroids and induction of labour. The synthetic steroid CDB-2914 binds to the progesterone and glucocort…

article 2003
·doi:10.1016/s0015-0282(03)01502-4
article 2003
Gynecologic and obstetric investigation ·doi:10.1159/000072329

Barrier contraceptive devices like the cervical cap and diaphragm and menstrual collecting devices may block menstrual flow, increase retrograde menstruation, and thus theoretically increase the likelihood of developing endometriosis or ade…

article 2002
·doi:10.1016/s0015-0282(01)03031-x
article 2002
·doi:10.1016/s0015-0282(02)03615-4